Nature Communications, Published online: 30 July 2026; doi:10.1038/s41467-026-76188-x Targeted lung delivery of therapeutics is critical for various respiratory diseases. Here, authors develop heteropolypeptide-decorated nanoparticles that exhibit lung targeting through in situ erythrocyte hitchhiking in a sequence-dependent manner, which is further used for the treatment of acute lung injury.